title: A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents.
abstract: OBJECTIVE
  To pool data on the role of thrombolytic agents in cardiopulmonary resuscitation (CPR) and evaluate the efficacy and safety of thrombolysis.
  
  
  METHODS
  The clinical studies in MEDLINE database from 1966 to August 2004 that studied the efficacy and safety in CPR with and without treatment with thrombolytic agents were assessed by a meta-analysis performed to evaluate the effect of the treatment.
  
  
  RESULTS
  A total of eight papers evaluating the effect of thrombolysis in CPR were identified. This meta-analysis showed that thrombolytic agents significantly improved the rate of return of spontaneous circulation, 24 h survival rate, survival to discharge and long-term neurological function in patients treated with CPR (p < 0.01). However, the patients receiving thrombolysis had a risk of severe bleeding (p < 0.01).
  
  
  CONCLUSIONS
  Thrombolytic agents during CPR can improve the survival rate to discharge and neurological function.
authors.affiliation: Department of Emergency, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, PR China.
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Qing-ling
authors.initials: QL
authors.lastname: Fu
authors.forename: Xiao-li
authors.initials: XL
authors.lastname: Jing
authors.forename: Yu-jie
authors.initials: YJ
authors.lastname: Li
authors.forename: Hong
authors.initials: H
authors.lastname: Zhan
authors.forename: Zhong-fu
authors.initials: ZF
authors.lastname: Ma
authors.forename: Xiao-xing
authors.initials: XX
authors.lastname: Liao
mesh_terms: D016887:Cardiopulmonary Resuscitation / Q000379:methods* / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006323:Heart Arrest / Q000401:mortality / Q000628:therapy; D006801:Humans; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents